Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adolescent Influenza Vaccine”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Post-approval studies (Phase 4)Study completedNCT01831934
What this trial is testing

Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)

Who this might be right for
MELAS Syndrome
Stanford University 22
Post-approval studies (Phase 4)Study completedNCT01069367
What this trial is testing

Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 100
Large-scale testing (Phase 3)Study completedNCT01209780
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Who this might be right for
Seasonal Influenza
Novartis Vaccines 3,116
Large-scale testing (Phase 3)Study completedNCT01967784
What this trial is testing

Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT01855945
What this trial is testing

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627
Large-scale testing (Phase 3)Ended earlyNCT03376321
What this trial is testing

Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection

Who this might be right for
Influenza A
Janssen Research & Development, LLC 334
Testing effectiveness (Phase 2)Study completedNCT01052402
What this trial is testing

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

Who this might be right for
Influenza, Avian
Alachua Government Services, Inc. 684
Large-scale testing (Phase 3)Study completedNCT06099873
What this trial is testing

Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

Who this might be right for
Respiratory Viral Infection
Nanjing Zenshine Pharmaceuticals 361
Post-approval studies (Phase 4)Study completedNCT01693380
What this trial is testing

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza

Who this might be right for
InfluenzaAcute Respiratory Infection
Butantan Institute 1,742
Not applicableStudy completedNCT01407978
What this trial is testing

Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

Who this might be right for
Novel 2009 Influenza H1N1Influenza, Human
Fluart Innovative Vaccine Ltd, Hungary 58
Post-approval studies (Phase 4)Study completedNCT00956111
What this trial is testing

A Clinical Trial With Influenza A/H1N1 Vaccines

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 1,614
Testing effectiveness (Phase 2)Study completedNCT00975572
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Jiangsu Province Centers for Disease Control and Prevention 2,200
Large-scale testing (Phase 3)Study completedNCT02621177
What this trial is testing

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 385
Post-approval studies (Phase 4)Study completedNCT01190215
What this trial is testing

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Who this might be right for
Influenza
GlaxoSmithKline 77
Large-scale testing (Phase 3)Study completedNCT00973700
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

Who this might be right for
Novel 2009 Influenza H1N1
Novartis Vaccines 784
Large-scale testing (Phase 3)Study completedNCT00645411
What this trial is testing

Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents

Who this might be right for
Influenza
Novartis 3,604
Post-approval studies (Phase 4)Study completedNCT02250274
What this trial is testing

Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents

Who this might be right for
Immune Response to Influenza VaccineInfluenza A Virus InfectionInfluenza B Virus Infection
Marshfield Clinic Research Foundation 131
Testing effectiveness (Phase 2)Study completedNCT00976469
What this trial is testing

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 400
Large-scale testing (Phase 3)Study completedNCT02621164
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 454
Large-scale testing (Phase 3)Study completedNCT02814643
What this trial is testing

Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma

Who this might be right for
Asthma
AstraZeneca 103
Next Page